Hydroxychloroquine hitting the headlines-retinal considerations

Eye (Lond). 2020 Jul;34(7):1158-1160. doi: 10.1038/s41433-020-0934-9. Epub 2020 May 19.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antirheumatic Agents* / adverse effects
  • COVID-19 Drug Treatment*
  • Humans
  • Hydroxychloroquine*
  • Retina* / drug effects
  • Retinal Diseases* / drug therapy
  • SARS-CoV-2

Substances

  • Antirheumatic Agents
  • Hydroxychloroquine